![]() |
Volumn 3, Issue 7, 2006, Pages 1192-
|
Questionable advertising of psychotropic medications and disease mongering [8]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ARIPIPRAZOLE;
PSYCHOTROPIC AGENT;
VENLAFAXINE;
ANTIDEPRESSANT AGENT;
NEUROLEPTIC AGENT;
PIPERAZINE DERIVATIVE;
QUINOLONE DERIVATIVE;
BIPOLAR DISORDER;
DEPRESSION;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG MANUFACTURE;
DRUG MARKETING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INFORMATION SERVICE;
LETTER;
PRESCRIPTION;
ADVERTIZING;
NOTE;
ADVERTISING AS TOPIC;
ANTIDEPRESSIVE AGENTS;
ANTIPSYCHOTIC AGENTS;
BIPOLAR DISORDER;
DRUG INDUSTRY;
HUMANS;
PIPERAZINES;
PSYCHOTROPIC DRUGS;
QUINOLONES;
|
EID: 33746469871
PISSN: 15491277
EISSN: 15491676
Source Type: Journal
DOI: 10.1371/journal.pmed.0030321 Document Type: Letter |
Times cited : (13)
|
References (8)
|